41. Giant cell arteritis Clinical trials / Disease details
Clinical trials : 128 / Drugs : 139 - (DrugBank : 36) / Drug target genes : 33 - Drug target pathways : 124
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02985424 (ClinicalTrials.gov) | May 2017 | 1/12/2016 | Polymyalgia Rheumatica and Giant Cell Arteritis | Polymyalgia Rheumatica and Giant Cell Arteritis - Three Challenges - Consequences of the Vasculitis Process, Osteoporosis and Malignancy: A Prospective Cohort Study Protocol | Polymyalgia Rheumatica;Giant Cell Arteritis | Other: 18F-FDG PET/CT | Svendborg Hospital | Odense University Hospital | Not yet recruiting | 18 Years | 95 Years | All | 80 | N/A | Denmark |